One potential complication was first reported in July 2024 when a study found people using semaglutide were at a Now, a new study recently published in the journal For this study, researchers analyzed health records from 2020 to 2023 of more than 139,000 Ontario residents with an average age of 66 and diagnosis of diabetes
Injecting into the Abdomen: Pros and Cons The abdomen is a popular site for Semaglutide injections, and it has its advantages and disadvantages
Open Calculator Tirzepatide Dosage Chart Review the typical weekly tirzepatide dosing progression from the starting dose through escalation and maintenance
54-year-old female: On semaglutide for 16 weeks, lost 26.3 pounds
A new clinical trial, co-led by endocrinologist and diabetes expert John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine has shown that the oral form of semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes and atherosclerotic cardiovascular disease, and/or chronic kidney disease
Multiple endocrine neoplasia syndrome type 2 (MEN2)
